There are 2789 resources available
1506MO - Incorporating genetic and non-genetic risk factors in breast cancer risk prediction for healthy women with non-informative genetic test result
Presenter: Anja Tüchler
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1507MO - Selection of quality indicators (QI) by non-hospital professionals for onco-hematology care pathway
Presenter: Mario di Palma
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1508MO - Rationalizing the use of off-label drugs (OLD) within a special medication (ME) program for cancer patients (pt): The Catalan Institute of Oncology (ICO) prognostic score (ICO MEscore)
Presenter: Lucia Notario Rincon
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1509MO - Adherence to the Food and Drug Administration (FDA) guidance for the co-development of two or more investigational new drugs in phase 1/2 cancer trials
Presenter: Justin Moyers
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1510MO_PR - European cancer patients’ perspectives on Immunotherapy
Presenter: Paraskevas Kosmidis
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
LBA19 - A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE)
Presenter: Sibylle Loibl
Session: Mini oral session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
387MO - Tumour mutation profiles and circulating tumour cells in metastatic colorectal cancer patients treated with FOLFIRI + cetuximab: A prospective ancillary study of the UNICANCER PRODIGE-28 trial
Presenter: Hélène Blons
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
388MO - Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapy
Presenter: Debora Basile
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
389MO - Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: A nested case-control matched analysis of an international, multi-centre, randomised controlled trial (FOxTROT)
Presenter: James Glasbey
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
390MO - Colorectal (CRC) cancer screening and diagnosis during the COVID-19 pandemic in Quebec, Canada
Presenter: Mustapha Tehfe
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast